Last reviewed · How we verify

NCT05338996

Addressing Health Disparities in Engagement, Retention, and Utilization of PrEP Among South Florida Women of Color

Completed NA Last updated 27 June 2023
What this trial tests

NA trial testing iENGAGE for PrEP in HIV Prevention in 72 participants. Completed in 31 May 2023.

Timeline
1 October 2021
Primary endpoint
31 May 2023
31 May 2023

Quick facts

Lead sponsorFlorida International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment72
Start date1 October 2021
Primary completion31 May 2023
Estimated completion31 May 2023
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Florida International University

Who can join

18 and older, female only, with HIV Prevention or PrEP Adherence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Women of color (WOC) in South Florida, the region with the highest HIV rates in the U.S., experience significant barriers to accessibility, uptake, and utilization of Pre-exposure prophylaxis (PrEP) for HIV prevention, despite FDA approval since 2012. The purpose of this study is to use a Community-Based Participatory Research (CBPR) approach to finalize, and pilot-test a multi-component evidence-based intervention to reduce health disparities in engagement, utilization, and retention in PrEP care, with the goal of improving HIV prevention outcomes for the target population of WOC in S. Florida, primarily African American, Latina, and Haitian women in 3 designated Ending the HIV Epidemic (EHE) counties: Miami-Dade, Broward, and Palm Beach counties.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for HIV Prevention

Currently open trials in the same condition.

Other Florida International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05338996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing